All lobbying filings
Tiber Creek Group
Tiber Creek Group filed a Q1 report for Tiber Creek Health Strategies, Inc. (On Behalf of Genentech, Inc.) on April 18, 2025, reporting $60,000 in lobbying income.
Lobbying for Tiber Creek Health Strategies, Inc. (On Behalf of Genentech, Inc.) · Government relations.
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 18, 2025
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia
Government bodies contacted
2
Lobbying activity
2
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part B Pricing Reform.
Issues related to the 340B Program - Public Health Service Act (PL 78-410).